Study reveals dual effects of new osteoporosis therapy on bone tissue  News-Medical.net

Sclerostin is a protein produced by osteocytes in the bone that inhibits bone formation. A recent analysis of results from a clinical trial reveals the beneficial ...

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.